New low concentration options in Freeflex ® IV bags join broadest portfolio of heparin sodium therapies LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi announced today it has introduced in the ...

When you have deep vein thrombosis (DVT), a blood clot in a vein deep inside your body, doctors try to keep the clot from getting bigger and stop new clots from forming. One of their top priorities is ...

The heparin frequently given before percutaneous coronary intervention (PCI) should be pushed to as early as possible in patients with ST-segment elevation myocardial infarction (STEMI), according to ...

Therapeutic-dose heparin appears to benefit noncritically-ill COVID-19 patients, but it does not reduce deaths or other adverse endpoints compared with usual-care thromboprophylaxis if it’s initiated ...

Researchers moved one step closer to the ability to make heparin in cultured cells. Heparin is a potent anti-coagulant and the most prescribed drug in hospitals, yet cell-culture-based production of ...

Taurolidine is an antibacterial and antifungal agent with a mechanism of action that is less prone to development of antimicrobial resistance. A taurolidine/heparin lock solution carries a lower risk ...

You have full access to this article via your institution. Figure 1: Comparison of the proton NMR spectra of synthesized OSCS at pH 7 and pH 5. The alternative text for this image may have been ...

Please provide your email address to receive an email when new articles are posted on . Patients with an allergic inflammatory skin reaction to subcutaneous heparin generally tolerated IV ...

In 97 consecutive patients who received heparin, efficacy, as assessed by a clinically satisfactory response, was not related to sex or age. Adverse reactions occurred in 18 out of 56 women (32 per ...

The Global Heparin Market is projected to grow steadily at a CAGR of approximately 5% by 2026. The market expansion is primarily driven by the increasing prevalence of chronic and lifestyle-related ...

LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi announced today it has introduced in the United States two new presentations of Heparin Sodium in convenient, ready-to-administer Freeflex ® IV bags.